Moleculin's Annamycin shows no significant heart toxicity in leukemia study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. MU
6. DFTX
7. APGE
8. LLY
9. RGNX
10. LCO

Go back to Moleculin's Annamycin shows no significant heart toxicity in leukemia study
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 3.11 +0.23 (7.99%)
Previous Close $2.88    52 Week High $9.58 
Open $3.01    52 Week Low $2.34 
Day High $3.11    P/E N/A 
Day Low $2.94    EPS $-0.34 
Volume 268,879